Judy Wilkins tried four different chemotherapy regiments over 18 grueling months to try to put her lymphoma into remission. Her team never could. But thanks to CAR T-cell therapy, an emerging immunotherapy treatment that is showing great promise in clinical trials nationwide, Wilkins is cancer-free. CAR (Chimeric Antigen Receptor) T-cell therapy is a form of cellular … Read more
Donor stem cell transplants and other cellular therapies are treatment approaches that harness the immune system to fight cancer using cells from the patient or from healthy donors. What are stem cell transplants? Stem cell transplants are used to treat blood-related cancers such as leukemia, lymphoma, and multiple myeloma, as well as certain non-cancerous blood … Read more
The Food and Drug Administration (FDA) announced today that a drug called CTL019 has become the first chimeric antigen receptor (CAR) T-cell therapy approved to treat a form of cancer. The decision means the drug can be used as standard therapy for the treatment of pediatric and young adult patients with B-cell acute lymphoblastic leukemia (ALL) … Read more
Geriatrician Tammy Hshieh, MD, MPH, introduces herself to patients by saying she is a specialist in aging and complexity. Almost inevitably, a cancer patient in his or her 70s, 80s, or 90s is dealing with more than a tumor – and that’s where Hshieh’s skills and experience can be an asset to the treating oncologist. … Read more
CAR T-cell therapy is a form of immunotherapy in which patients’ T cells are modified to become better at tracking down and destroying tumor cells. CAR T cells are made by extracting thousands of a patient’s T cells, sending them to a lab where they’re outfitted with genes and proteins that improve their cancer-fighting prowess, and … Read more
A stem cell transplant can be a lifesaving treatment for patients with leukemia, lymphoma, multiple myeloma, or certain blood-related disorders. In many cases, however, transplants increase patients’ risk for an array of long-term health problems, often caused by the high doses of chemotherapy and/or radiation therapy used prior to the transplant. Dana-Farber’s Adult Stem Cell Survivorship … Read more
In the high-stakes contest of hide-and-seek between cancer cells and the human immune system, the advantage doesn’t always lie with the body’s defenders. A new approach to treatment, known as CAR T-cell therapy, may shift that balance of power. Cancer cells conceal themselves from the immune system not by barricading themselves in an impenetrable shell, … Read more
CAR T-cell therapy is a kind of cellular therapy, which uses a patient’s own immune system T cells to rally an attack on cancer. CAR T cells are made by removing T cells from the blood, modifying them in a lab to intensify the immune system’s natural response to cancer, and re-injecting them into the patient. CAR … Read more
Treatment of blood-related, or hematologic, cancers is seizing on insights into the basic genetic wiring of cancer cells and the body’s system for finding and attacking those cells. Research presentations at the annual American Society of Hematology (ASH) meeting in December gave evidence of how broad, and rapid, the progress is. Targeted therapies, new combinations … Read more
By Ronni Gordon When my year of isolation ended after a stem cell transplant at Dana-Farber/Brigham and Women’s Cancer Center in 2003, I looked for a blood cancer support group near my home in western Massachusetts. I found support groups for just about everyone except patients like me with acute myeloid leukemia (AML) and other … Read more
For clinical social workers Annette Quinn, MSW, LICSW, and Sara Nemitz, MSW, LICSW, each day is unique. Part of Dana-Farber’s department of Psychosocial Oncology and Palliative Care, Quinn and Nemitz work closely with patients and their families to provide support during treatment, addressing the new anxieties and concerns many patients face after a cancer diagnosis. … Read more
A stem cell transplant is a procedure during which doctors either replace diseased or ineffective stem cells with healthy new stem cells or allow high-dose treatment for lymphoma, some testicular cancers, and other diseases. It is often lifesaving for patients with blood cancer and serious blood disorders. A person may need a transplant for a … Read more
A fire truck pulls into the truck bay and idles for a minute or two as a firefighter attaches tubing to filter the exhaust out of the station. The firefighter’s face may be close to the exhaust for 30 seconds while the tubing is attached. It’s a routine task, one that’s performed by the same … Read more
By Dana Mendes Like many high school students, I was eager to start a new chapter of my life after graduating in 2015. I had committed to play field hockey at Assumption College in Worcester, Massachusetts, that fall, and spent the summer working out alongside my new teammates – determined to prove myself on the … Read more
The holidays can be a happy time of family gatherings and traditions, but the combination of extended family and friends and cold and flu season can be dangerous for patients who are immunocompromised following recent stem cell transplants to treat blood cancers including multiple myeloma, leukemia, lymphoma, and related disorders. “When transplant patients leave the … Read more
By Deb Osborne On that beautiful day in October, filled with all the excitement life has to offer, I didn’t realize how important those words would become. Caught up in the wonderment of our wedding day, the magnitude of those words did not resonate with me until seven years ago when my husband was diagnosed … Read more
After Lacey Martin’s leukemia didn’t respond to initial rounds of chemotherapy and after she spent 10 weeks hospitalized for a stem cell transplant, the 11-year-old New Hampshire girl went home March 2 with an external line for medications that her mother would have to flush and clean twice a day. Lacey’s immune system and infection-fighting … Read more
Combination therapy, the use of more than one type of therapy in treating a patient, is a hallmark of cancer treatment. The complexity of the disease – its tendency to spread beyond its original site and become resistant to certain drugs, and its genetic diversity – underscores the need for a variety of approaches to … Read more
Two decades ago, Dana-Farber blood cancer researcher Sophia Adamia, PhD, left her home in Georgia, a country with a turbulent past located at the crossroads of Western Asia and Eastern Europe. Not until last May did she return to Georgia, to participate in a conference organized by the State Minister of Georgia for Diaspora Issues. … Read more
A reduced-intensity stem cell transplant, also known as a ‘mini’ transplant, is a modified form of a procedure that replaces a patient’s blood-forming stem cells with those of a compatible donor. Mini-transplant patients receive lower doses of chemotherapy than are used in a full-intensity, or myeloablative, transplant, and, in general, receive no radiation therapy. The … Read more